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Abstract
During calcification of bone, large amounts of
phosphate (Pi) must be transported from the
circulation to the osteoid. Likely candidates for
osteoblast Pi transport are the type II sodium-
phosphate cotransporters NaPi-IIa and NaPi-IIb that
facilitate transcellular Pi flux in kidney and intestine,
respectively. We have therefore determined the
cotransporters’ expression in osteoblast-like cells. We
have also studied the cotransporters’ regulation by
Pi and during mineralization in vitro. Phosphate uptake
and cotransporter protein expression was investigated
at early, late and mineralizing culture stages of mouse
(MC3T3-E1) and rat (UMR-106) osteoblast-like cells.
Both NaPi-IIa and NaPi-IIb were expressed by both
osteoblast-like cell lines. NaPi-IIa was upregulated in
both cell lines one week after confluency. After 7 days
in 3mM Pi NaPi-IIa was strongly upregulated in both
cell lines. NaPi-IIb expression was unaffected by both
culture stage and Pi supplementation. The expression
of both cotransporters was unaffected by Pi
deprivation. In vitro mineralization at 1.5mM Pi was
preceded by a three-fold increase in osteoblast
sodium-dependent Pi uptake and a corresponding
upregulation of both NaPi-IIa and NaPi-IIb. Their
expression thus seem regulated by phosphate in a
manner consistent with their playing a role in
transcellular Pi flux during mineralization.
Introduction
During bone calcification the constituent ions of
hydroxyapatite, calcium and phosphate (Pi), must be
translocated from the circulation to sites of mineral
formation. In order for osteoblasts to regulate the rate of
mineralization acccording to physiological need, it would
be advantageous for this process to be under cellular
control as opposed to free diffusion. Ion concentrations
in the osteoid, the mineralizing space between osteoblasts
and calcified bone, are elevated compared to the
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extracellular fluid, suggesting that ion transport is
directional, energy-dependent and at least partly
transcellular [1-4]. The transport of calcium to mineralizing
bone is most likely performed by uptake through L-type
calcium channels and efflux via sodium-calcium
exchangers facing the osteoid space [3], and inhibition of
both L-type calcium channels and Na+-Ca2+ exchangers
has been shown to diminish bone formation [2-3].
Additionally, both odontoblast-like cells and bone cells in
vivo have been demonstrated to perform directional
calcium transport [4, 5].
The pathway of phosphate to the osteoid has been
much less studied than calcium transport. The osteoblasts
have so far been shown to express the two type III
cotransporters Pit-1 and Pit-2 [6-9]. Pit-1 has been more
investigated and have been shown to be upregulated as
osteoblast differentiation progresses and to be regulated
by certain osteogenic factors such as BMP-2 [10].
However the expression of Pit-1 in native bone is weak
and expression in osteoblasts in vivo could not be detected
by in-situ hybridization [9]. In addition, characterization
of osteoblast Pi uptake have shown that the Km for
phosphate uptake is closer to what would be expected
from the type II Na+-Pi cotransporters and that osteoblast
Pi uptake can be inhibited by phosphonoformic acid (PFA)
[11-12]. PFA is a commonly used inhibitor of type II Na+-
Pi cotransporters but only inhibits type III cotransporters
weakly (Pit-2 [13], Pit-1 [14] and unpublished, personal
communication Dr Ian Forster). The type III
cotransporters are ubiquitously expressed and thought to
perform a housekeeping function in cellular Pi metabolism,
but have not been implicated in transcellular Pi flux [11].
It is likely that they perform the same role in osteoblasts.
In other tissues performing transcellular phosphate
transport, such as kidney and intestine, cellular Pi uptake
is mediated by type II Na+-Pi cotransporters of the SLC34
family [11-12]. NaPi-IIa and NaPi-IIc are found in the
proximal tubule of the nephron, while Pi absorption in the
small intestine is performed by NaPi-IIb [11-12]. NaPi-
IIb is also involved in transcellular Pi flux in liver and
salivary glands [15-16]. These cotransporters catalyze
uptake of Pi into cells utilizing energy provided by the
cotransport of two to three sodium ions [11-12]. The
cotransporters in the kidney and intestine are up-regulated
in hypophosphatemia and down-regulated by excess serum
Pi (the latter leading to reduced Pi uptake in the intestine
and increased Pi wasting in the kidney) permitting the
organism to maintain Pi homeostasis [11-12, 17]. Their
role in transcellular Pi flux make members of the type II
Na+-Pi cotransporter family prime candidates for
osteoblastic transcellular Pi transport. These
cotransporters (NaPi-IIa and NaPi-IIb) have also been
found in mineral-forming odontoblasts, MRPC-1
odontoblast-like cells and ameloblasts and their
coexpression seems to be a common feature of some
mineral-forming cell types [18-19]. Chondrocytes and
osteoclasts have also been shown to express NaPi-IIa
while NaPi-IIb has not been studied in those cell types
[20-21]. This contrasts with kidney and intestine, where
either NaPi-IIa or NaPi-IIb is found alone [11-12].
In MRPC-1 odontoblast-like cells, Pi uptake and
NaPi-IIa cotransporter protein are found to be upregulated
prior to the formation of mineral in vitro [18]. We
hypothesized that a similar mechanism would be
employed by osteoblasts, the cotransporters being
upregulated to facilitate mineral formation. An important
role of the osteoblasts is to help maintain ion homeostasis
by removing excess Ca2+ and Pi from the circulation to
storage in bone. If type II cotransporters are involved in
osteoblast Pi transport they may therefore be up-regulated
in response to elevated serum Pi to increase Pi flux into
bone and thus help to reduce serum Pi concentrations to
its normal level. Equally, Pi starvation may have an
opposite effect, and precipitate a down-regulation of
osteoblast sodium-phosphate cotransporters involved in
transcellular Pi flux to limit bone formation when the ions
are scarce.
Our goal was to determine the expression of NaPi-
IIa and NaPi-IIb in osteoblast-like cells from mouse
(MC3T3-E1) and rat (UMR-106). Two independent cell
lines from different species were used to ascertain that
the findings were of general importance and not limited
to a certain cell line. We examined the effects of
increased and decreased phosphate levels on expression
of type II Na+-Pi cotransporters and Pi uptake activity of
osteoblast-like cells. Expression of cotransporters before
and during mineral formation in vitro was also assessed.
Materials and Methods
Cell culture
UMR-106.01 and MC3T3-E1.14 cells (ATCC, Manassas,
VA, USA) were seeded in 12 well plates for Pi uptake experiments
and von Kossa staining, or in 25cm2 flasks for protein
preparations (cell culture vessels from Corning Costar, Acton,
MA, USA). Cells were grown in alpha Minimal Essential
Medium (αMEM, Gibco, Invitrogen, Carlsbad, CA, USA) with
the addition of 10% (v/v) fetal calf serum, 100U/ml penicillin,
100µg/ml streptomycin, 2mM L-glutamine and 50µg/ml ascorbic
acid (Gibco). Medium was exchanged every second day of the
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culture period and always the day before uptake measurements
or protein preparation. In the case of mineralizing cultures,
inorganic phosphate was initially supplemented to 3mM final
concentration. As this gave abnormal Pi uptakes, phosphate
was later kept at 1.5mM to promote mineralization of UMR-106
cultures while this experiment could not be performed with
MC3T3-E1 cells, see discussion.
For Pi starvation cells were first grown to confluency and
then switched to a chemically defined, Pi-free, DMEM-like,
serum free medium with 1% (w/v) BSA [22]. Cells were allowed
to adapt for two days to the new medium, supplemented with
1mM Pi, after which the cultures were changed to a Pi-free
medium for 72h. Control cultures were maintained in the same
medium supplemented with 1mM Pi. Opposum kidney cells
(OK), the most studied system of NaPi-IIa regulation by Pi,
were cultured as described previously and used as controls in
high Pi, Pi starvation experiments and pyrophosphate (PPi)
inhibition studies [22-23].
Western blotting
Membrane fractions were isolated from cultures of
osteoblast-like cells grown in 25cm2 flasks using the method
described by Pfister et. al. [24]. Isolations were done from at
least three independent cultures when quantifying NaPi-IIa or
NaPi-IIb expression in osteoblast-like cell lines. Protein
concentration was determined using the DC Protein Assay (Bio-
Rad, Hercules, CA, USA). Membranes were stored at -80°C.
Mouse kidney brush border membranes and small intestinal
membranes were used as positive controls for NaPi-IIa and
NaPi-IIb, respectively [25-26]. 30µg of membrane protein (2µg
of kidney brush border membranes, or 10µg of intestinal brush
border membranes) were denatured at 97°C for 2min under non-
reducing conditions, separated on 10% SDS-PAGE gels and
transferred to nitrocellulose membranes. Na+-Pi cotransporter
proteins were detected by antibodies specific for N-terminal
peptides of either NaPi-IIa or NaPi-IIb as described previously
[27-28]. To verify the identity of bands detected, two
independent antibodies directed against the C-termini of the
cotransporters were also used in control experiments [27-28].
Bound antibody was visualized by chemiluminescence (Super
Signal west Pico, Pierce, Rockford, IL, USA). Band intensities
were normalized against β-actin detected by a mouse
monoclonal anti β-actin antibody (Sigma, St. Louis, MO, USA,
Cat. No. A-5316). For quantification, 6 independent protein
isolates were used in each experiment. Peptide protection was
performed for N-terminal specific antibodies by incubating the
blots in the presence of 100µg/ml immunogenic peptide to block
antibody binding to the transferred protein.
Immunostainings
The subcellular localization of NaPi-IIa and NaPi-IIb in
cultured cells grown on coverslips were determined by
immunofluorescence. Cells were washed in PBS, fixed in 3%
(w/v) paraformaldehyde for 10min, washed again and then
blocked with 20mM glycine in PBS for 10min. Cells were then
permeabilized for 30min with 0.1% (w/v) Saponin in PBS. Primary
antibody (against NaPi-IIa or NaPi-IIb, as described above)
was added for 2h at a dilution of 1:100 in PBS-Saponin. For
negative controls rabbit pre-immune serum was used at the
same duilution. After washing, secondary antibody, FITC-
conjugated goat anti-rabbit IgG (Molecular Probes, Invitrogen,
Carlsbad, CA, USA) diluted 1:50 in PBS-Saponin, together with
Phalloidin Alexa Fluor (Molecular Probes) diluted 1:20, was
added for 30min. Cover slips were washed, mounted and then
analyzed by confocal microscopy (Leica, Wetzlar, Germany,
Imaris imaging software v. 3.04, Bitplane AG, Zürich,
Switzerland).
Phosphate uptake
Cells in 12 well culture plates were washed twice in Hank’s
balanced salt solution with Na+ adjusted to 100mM, Pi at 1 mM
(added as potassium salt) and10mM Hepes-Tris, pH 7.2.
Sodium-independent uptake was determined by substituting
sodium in the uptake buffer with equimolar choline. Cells were
then incubated in the same buffer containing 1µCi /ml 32Pi (New
England Nuclear, PerkinElmer, Wellesley, MA, USA). In time
course experiments uptake was stopped after 2, 4, 8 or 16min
by the removal of uptake buffer and three consecutive washes
with ice-cold uptake buffer without radionuclide. The cell layer
was then lysed by addition of 0.5ml 0.2M NaOH, homogenized
by pipetting and centrifuged to remove cell debris and
collagenous extracellular matrix. Protein concentration of lysates
was determined using the DC protein assay (Bio-Rad) according
to the manufacturer’s instructions. Aliquots of lysates and
uptake buffer were counted by scintillation. Phosphate uptake
was expressed as nmol Pi/mg protein.
To determine the apparent affinity for Pi, Pi concentration
in the uptake buffer was varied between 0.01 and 1mM. pH
dependency of Pi uptake was investigated by varying the pH
of Hepes-Tris in uptake buffers between 5.6 and 7.4. The ability
of pyrophosphate (PPi) (Sigma) to inhibit sodium-dependent
phosphate uptake in UMR-106 and OK cells was assessed in a
concentration range of 0 to 3mM pyrophosphate.
Phosphonoformic acid (PFA) inhibition of Pi uptake was studied
at concentrations between 0 and 3mM PFA. PFA is a commonly
used inhibitor of sodium-phosphate cotransporters, specific
for the type II cotransporters but only weakly inhibiting the
type III cotransporters,[11-13, Pit-1: [14] and unpublished, Dr.
Ian Forster, personal communication]. For these experiments
the uptake was allowed to proceed for 6min, within the linear
phase of Pi uptake, and also when single time point
measurements were done. For pH and inhibition measurements,
Pi was kept at 0.5mM. For time-course and Pi affinity experiments
data were fitted to the Michaelis-Menten equation by non-
linear regression , in the case of Pi affinity after subtraction of
the sodium-independent component of uptake. (Prism,
Graphpad, San Diego, CA, USA).
Pi uptake was characterized in cells at confluency, at 1
week post-confluency, after culture in 3mM Pi for 24h or 7 days
and in cells starved of Pi for 72h. Uptake experiments were also
performed every second day in cells cultured under mineralizing
conditions at 1.5mM Pi.
All Pi uptake experiments were performed at 30°C. All
experiments were repeated at least 3 times.
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von Kossa-staining
Mineralized nodules produced by cultured osteoblast-
like cells were stained according to a protocol by von Kossa as
modified by Krutsay [29]. Cells were fixed in ethanol, washed
and incubated under normal lighting for 45min in 5% (w/v)
AgNO3. Cells were then rinsed and the staining stabilized in
16% (w/v) paraformaldehyde, 800mM Na2CO3 for 2min. After
rinsing in water, unspecific silver stain was removed by
reduction for 30s in a freshly prepared mixture of 400mM Na2S2O3
and 300mM K3(Fe(CN)6 (20:1). Cells were rinsed again and
photographed. Counterstaining was not performed.
All statistical tests and non linear curve-fittings were
performed using Prism software (Graphpad), statistical tests
utilized ANOVA with a p< 0.05 considered significant. Unless
otherwise stated all chemicals were from Sigma and of the
highest purity available.
Fig. 1. Expression of NaPi-IIa and NaPi-IIb proteins in osteoblast-like cells. Western blot of NaPi-IIa and NaPi-IIb in osteoblast-
like cells. With antibodies specific for N-terminal peptides of the cotransporters, NaPi-IIa was seen at 80 and 160kDa while NaPi-
IIb could be detected at 105 and 210kDa. The higher molecular weight bands representing dimers of the cotransporters. The
signals could be abolished by preincunbation of the primary antibodies with the corresponding immunogenic peptides. When
repeating the experiment with antibodies directed against C-terminal peptides of the cotranporters gave rise to the same bands,
again confirming their identity. Negative control experiments using pre-immune rabbit serum detected no bands corresponding
to the cotransporters (Neg.). M: MC3T3-E1 membrane protein, U: UMR-106 membrane protein. K: Kidney brush border membrane.
I: Intestinal brush border membrane.
Lundquist/Murer/BiberCell Physiol Biochem 2007;19:43-56
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Fig. 2. Confocal immunofluorescent detection of NaPi-IIa and NaPi-IIb in osteoblast-like cells. Both Na+-Pi cotransporters were
found in the osteoblasts cell membrane and colocalized with β-actin as can be seen by the predominantly yellow merged signal.
Some intracellular staining for NaPi-IIb was evident. Membrane localization was generally more pronounced in UMR-106 than in
MC3T3-E1 cells. Negative controls showed weak unspecific staining. Green: NaPi-IIa or NaPi-IIb. Red: β-actin. Yellow: Merge.
Neg: Negative control. Lower panels shows a cross section (z-axis) through the center line, apical side upwards.
Results
Detection of type II Na+-Pi cotransporters in
osteoblast-like cells
Using antibodies directed against N-terminal peptides
of NaPi-IIa and NaPi-IIb, both cotransporters could be
detected in membrane fractions derived from UMR-106
and MC3T3-E1 cells (Fig. 1, left). NaPi-IIa was seen as
bands of 80 and 160kDa, while NaPi-IIb was detected
as bands of 105 and 210kDa; in each case the higher
molecular weight bands likely represented a dimer of the
cotransporter. In the case of NaPi-IIa, the 160kDa band
was much stronger than the band at 80kDa, while for
NaPi-IIb the 105kDa band dominated. In kidney (NaPi-
IIa) and intestine (NaPi-IIb) positive controls the same
relationship between the weaker and stronger band of
each cotransporter was seen. As the dominant bands
under all tested conditions amounted to a large majority
of the total signal, and as the stronger and weaker bands
always showed the same changes, in later experiments
only the dominant band of each respective cotransporter
is shown and quantified. Both NaPi-IIa and NaPi-IIb
signals could be blocked by preincubation of the primary
antibody with immunogenic peptide (Fig 1, middle panels).
To verify the identity of the bands, Western blots were
repeated with antibodies directed against C-terminal
peptides of the cotransporters, again detecting the same
bands in both cell lines (Fig. 1, right panels). Using rabbit
pre-immune serum no corresponding bands were visible
(Fig. 1, bottom).
Immunofluorescent detection of cotransporters in
cultured cells revealed expression of both NaPi-IIa and
Osteoblast Type II Na+-Pi Cotransporters Cell Physiol Biochem 2007;19:43-56
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NaPi-IIb in both cell lines used (Fig. 2). Both
cotransporters were detected by confocal microscopy in
the cell membrane and colocalized with β-actin.
Cotransporters were predominantly, but not exclusively,
found at the apical face of osteoblastic cells. Some
staining was also found on lateral sides and in some cases
a weak staining was seen at the basolateral membrane.
The polarized distribution of Na+-Pi cotransporters was
more pronounced for UMR-106 than for MC3T3-E1
cells. At this stage MC3T3-E1 cells showed a distended,
pre-osteoblastic morphology. In later culture stages the
cells showed a more pronounced polarization and
columnar morphology. Pre-immune serum yielded no or
weak staining of cultured cells. As the forming collagenous
matrix led to a large autofluorescence in samples from
late culture stages, immunofluorescence analyses were
only performed on cells at early confluency.
Characteristics of Pi uptake in UMR-106 and
MC3T3-E1 cells
At confluency both cell lines showed a pronounced
sodium-dependent Pi uptake. Uptake was linear during
the first eight minutes (Fig. 3). Kmapp, obtained from fitting
the Michaelis-Menten equation to the data in Fig. 3, for
Pi were 135±18 µM in UMR-106, and 113±15µM in
MC3T3-E1 cells, showing no significant difference
between the two cell lines (Fig. 3). At confluency,
MC3T3-E1 Pi uptake increased with increasing pH, while
pH had little effect on Pi uptake in UMR-106 cells except
for an increase in uptake at the most acidic condition
Fig. 3. Characterization of Pi uptake in osteoblast-like cells.
Both cell lines showed a pronounced sodium-dependent Pi
uptake, while sodium-independent uptake amounted to
approximately 20% of total uptakes. Apparent Pi affinity, after
subtraction of the sodium independent component, was for
UMR-106 135±18µM and for MC3T3-E1 113±15µM (non-linear
regression curve fits to the Michaelis-Menten equation). Kmapp
for Pi was not significantly different between the cell lines.
MC3T3-E1 cells Pi uptake was positively correlated with pH at
both culture stages. In contrast UMR-106 Pi uptake at
confluency was pH-independent over most of the range tested
but showed an inverse pH dependence for the lowest pH values.
One week later UMR-106 Pi uptake showed the same positive
pH dependence as seen in MC3T3-E1 cells. PFA at 1 mM
inhibited 65-75% of the sodium-dependent Pi uptake in both
cell lines. Higher concentrations of PFA left an uninhibitable
component of Pi uptake amounting to approximately 30%.
Curves for Pi affinity, PFA inhibition and pH dependency of
uptakes are shown after subtraction of sodium-independent Pi
uptake.
(pH 5.6) (Fig. 3). Pi affinity, PFA inhibition and pH
dependency curves in figure 4 show sodium dependent
components of Pi uptakes after subtraction of sodium-
independent Pi uptake.
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PFA at 1 mM inhibited 65-75% of the sodium-
dependent Pi uptake in both cell lines (Fig. 3). Higher
concentrations of PFA left an uninhibitable component of
Pi uptake amounting to approximately 30%. This suggests
that the type II cotransporters are the major catalysts of
osteoblast Pi uptake while the type III cotransporters are
responsible for approximately 30% of the total sodium-
dependent Pi uptake. Pyrophosphate in concentrations
up to 3mM did not inhibit sodium-dependent Pi uptake in
either osteoblastic cells or in OK cells. This was not
changed by addition of levamizole to the uptake solutions
to inhibit alkaline phosphatase hydrolysis of PPi (data
not shown).
Fig. 4. Regulation of NaPi-IIa and NaPi-IIb expression in osteoblast-like cells by culture stage and inorganic phosphate.
Expression of NaPI-IIa, shown at 160kDa, was influenced by both time in culture (confluency or 7 days post-confluency) and
supplementation of Pi to 3mM (24h or 7 days) in both cell lines. Levels of NaPi-IIb, shown at 105kDa, were not affected by these
conditions, quantification showed no significant differences between groups. Quantification showed that NaPi-IIa was decreased
after 24 h in 3mM Pi in UMR-106 but not in MC3T3-E1 cells (UMR-106: -49±6%, **: p<0.01; MC3T3-E1: -20±12%, NS, SEM, N=6)
and that the cotransporter was upregulated 7 days post-confluency (UMR-106: +66±8%, **: p<0.01; MC3T3-E1: +84±26%, *:
p<0.05, SEM, N=6) and after long-term treatment with 3mM Pi for 7 days (UMR-106: +287±75%, **: p<0.01; MC3T3-E1: +510±83%,
**: p<0.01, SEM, N=6) all as compared with the expression level at confluency (expression level at confluency set to 1, dotted
line). For each condition three lanes of three parallel membrane protein isolations are shown. Lower panels show β-actin loading
controls. Conf: confluency.
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The effects of culture stage on expression and
activity of Na+-Pi cotransporters in osteoblast-
like cells
Sodium-dependent Pi uptake in UMR-106 cells
showed differences in pH dependency a week after
confluency, compared with data from an early confluent
stage. Neither the magnitude nor the Kmapp of Pi measured
at pH 7.2 uptake one week post-confluency was
significantly different from the early confluent stage, in
either cell line. In UMR-106 cells, pH dependency
changed from being essentially pH independent in the
6.2-7.4 range at early confluency, into showing a clear
pH dependency, uptake increasing with increasing pH
over the entire pH range 7 days after confluency (Fig.
3). This behaviour is now similar to that seen in MC3T3-
E1 cells at both early and late confluency (Fig. 3). The
pH dependency of MC3T3-E1 Pi uptake was identical at
both culture stages (Fig. 3).
As shown in Figure 4, NaPi-IIa membrane protein
was increased in both cell lines from confluency to a
culture stage one week later (UMR-106: +66±8%, **:
p<0.01; MC3T3-E1: +84±26%, *: p<0.05, SEM, N=6).
The expression of NaPi-IIb was not changed by time in
culture, in either cell line.
The effects of Pi supplementation and starvation
on expression and activity of Na+-Pi
cotransporters in osteoblast-like cells
When performing Pi uptake experiments on
osteoblastic cells cultured in 3 mM Pi (added as phosphate
or β-glycerophosphate) to promote mineralization, an
approximately ten-fold increase in retained Pi in the wells
was seen within one day of Pi supplementation (at which
time mineral had started to form). This retention was not
sodium-dependent (data not shown). The retention was
also seen after first fixing cells in paraformaldehyde and
removing cell membranes, showing that it was not a cell-
dependent process. Neither was it due to binding to the
mineralized matrix, as returning cultures to normal medium
normalized uptake characteristics within 24h, while the
mineralized ECM remained. Also, in MC3T3-E1 cells
sodium-independent Pi retention was induced at 2mM Pi
while mineralization only took place above 3mM Pi. As
the magnitude of Pi binding far exceeded sodium-
dependent Pi uptake, characterization of Pi uptake could
not be performed for cells cultured in 3mM Pi. In contrast,
OK cell controls responded to 3mM phosphate with a
down regulation of sodium-dependent Pi uptake without
changes in sodium-independent uptake, as has been
described earlier (data not shown) [6].
Fig. 5. Effects of Pi starvation on UMR-106 Pi uptake, NaPi-IIa
and NaPi-IIb expression. A. Pi uptake: Phosphate starvation
for 72h led to a small increase (approximately 25%) in UMR-106
sodium-dependent Pi uptake. (**, p<0.01) Sodium-independent
Pi uptake was unaffected by Pi starvation. Pi: Culture in the
precense or absence of Pi. Na
+: Uptake performed in the presence
or absence of Na+. B. Expression of NaPi-IIa (160kDa) and NaPi-
IIb (105kDa). Levels of neither cotransporter changed in
membrane protein fractions from UMR-106 cells in response to
Pi starvation. For each condition three lanes of three parallel
membrane protein isolations are shown. Lower panels show β-
actin loading controls.
Pi supplementation to 3mM caused a decrease in
the membrane expression of NaPi-IIa in UMR-106 cells
within 24h while MC3T3 NaPi-IIa expression remained
unchanged (UMR-106: -49±6%, **: p<0.01; MC3T3-E1:
-20±12%, NS, SEM, N=6) (Fig. 4). However, after 7
days in 3mM Pi this phenomenon was reversed and
membrane expression of NaPi-IIa was strongly increased
in both cell lines as compared to the levels at confluency
(UMR-106: +287±75%, **: p<0.01; MC3T3-E1:
+510±83%, **: p<0.01, SEM, N=6), a stronger
A
B
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Fig. 6. Pi uptake and NaPi-IIa and NaPi-IIb expression in
UMR-106 cells during formation of mineral in vitro. A.
Development of UMR-106  Pi uptake 7-17 days after Pi supple-
mentation to 1.5mM. Day 0 denotes confluency of cultures.
Sodium-dependent uptake increases from day 9-15. Stars
denote significant changes as compared with the previous
time point, (*: p<0.05; **: p<0.01, N=3). B. Development of
UMR-106Pi uptake during culture in normal medium at a Pi
concentration of 1mM. No changes in Pi uptake seen with
time. C. Mineral starts forming at day 16 after Pi
supplementation to 1.5mM as visualized by von Kossa
staining. No mineral could be detected at day15 or earlier.
No mineral forms in normal medium. D. Western blot of NaPi-
IIa (160kDa) and NaPi-IIb (105kDa) in UMR-106 cells. Both
NaPi-IIa and NaPi-IIb are upregulated at mineralization after
16 days in 1.5mM Pi. For each condition three lanes of three
parallel membrane protein isolations are shown. Lower panels
show β-actin loading controls. E. Quantification of NaPi-IIa
and IIb expression shown in panel D, NaPi-IIa increased by
59±18% (SEM, **: p<0.01, N=6) after 16 days of treatment
with 1.5mM Pi, while NaPi-IIb increased by 188±11% (SEM,
***: p<0.001, N=6), as compared to untreated controls in
1mM Pi medium (expression level set to 1, shown by dotted
line).
upregulation of NaPi-IIa than extended culture time alone.
All data as compared to the expression level at confluency.
In contrast, in both cell lines expression of NaPi-IIb was
unaffected by Pi supplementation to 3mM. (Fig. 4).
In the Pi starvation experiment, culturing of UMR-
106 in Pi free medium for 72h led to a small but significant
(**: p<0.01) increase of 25-30% in cellular sodium-
dependent phosphate uptake (Fig. 5A) while other Pi
uptake characteristics were unchanged (data not shown).
No significant changes in NaPi-IIa or NaPi-IIb
expression were detected (Fig. 5B). Repeating the
experiment with MC3T3-E1 cells gave the same results
(data not shown). OK cell controls strongly upregulated
their sodium-dependent Pi uptake by approximately 200%
under the same culture conditions, as has been described
previously (data not shown) [11].
Pi uptake and Na
+-Pi cotransporter expression
in mineralizing UMR-106 cells
We found that sodium-independent Pi retention in
osteoblast cultures was rapidly induced at medium Pi
concentrations above 2mM. A phosphate concentration
of 1.5mM in the culture medium was therefore selected
to study Pi uptake and cotransporter expression under
mineralizing conditions in UMR-106 cells. The experiment
was not performed with MC3T3-E1 cells, see discussion.
A
B
C
D
E
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Increasing the concentration of Pi in cell culture
medium from 1 to 1.5mM led to no short term change in
cellular Pi uptake. In UMR-106 cells sodium-dependent
phosphate uptake began increasing at day 9 after Pi
supplementation to 1.5mM (Fig 6A). Sodium-dependent
uptake peaked at a level approximately 3 times higher
than basal uptake on day 15-17 (+239±11%, ***: p<0.0=1,
SEM, N=3). Mineral could be clearly seen in the cultures
from day 16 (Fig. 6C). In UMR-106 cells cultured in
standard medium, only small changes in Pi uptake were
seen over time (Fig. 6B) and the cultures showed no
mineral formation (Fig. 6C). In mineralizing cultures, as
well as control cultures, around 70% of Pi uptake could
be inhibited by PFA showing that the majority of Pi uptake
under all conditions was catalyzed by type II
cotransporters. The smaller PFA uninhibitable component
catalyzed by type III cotransporters did increase in
absolute magnitude during mineral formation, probably
due to an upregulation of Pit-1 as has been shown
previously [10].
In membrane samples from UMR-106 cells cultured
for 16 days in 1.5mM Pi, at which time Pi uptake had
increased and mineral started forming, a clear upregulation
of NaPi-IIb as compared to the expression level in normal
culture (+188±11%, ***: p<0.001, SEM, N=6) could be
detected. NaPi-IIa expression was also increased
(+59±18%, **: p<0.01, SEM, N=6) but to a lesser extent
than NaPi-IIb (Fig. 6D, E). The magnitude of Na+-Pi
cotransporter upregulation was thus well correlated with
the increase seen in sodium-dependent Pi uptake.
Discussion
We have shown that rat and mouse osteoblast-like
cells express two type II Na+-Pi cotransporters, NaPi-
IIa and NaPi-IIb. As these cotransporters are respectively
associated with epithelial transcellular Pi fluxes in kidney
and intestine, and co-express in several cell types
producing calcified tissues [18-19], we hypothesized that
they would play a role in the flux of phosphate from the
circulation to mineralizing calcified tissues. In this study
we have demonstrated that NaPi-IIa but not NaPi-IIb is
upregulated in osteoblast-like cells by relatively short-term
increases in Pi concentration. We have also established
that neither cotransporter is regulated by Pi starvation,
whereas both cotransporters are upregulated
concomitantly with increased cellular sodium-dependent
Pi uptake prior to formation of mineral in vitro. This is
consistent with the osteoblasts’ role in bone calcification
and in maintaining phosphate homeostasis, and supports
a role for type II Na+-Pi cotransporters in mediating
regulated Pi transport in osteoblasts.
Both cotransporters could be detected in membrane
fractions from both osteoblastic cell lines by western
blotting, using two independent antibodies for each
cotransporter. Both cotransporters could be detected both
as monomers and what is likely dimers of the
cotransporters, the dimer being the most abundant form
of NaPi-IIa, while NaPi-IIb was primarily found as a
monomer. It has been shown that NaPi-IIa to a large
extent dimerizes when expressed in Xenopus laevis
oocytes [30 and unpublished, Dr S Gisler, personal
communication], while NaPi-IIb has not been studied in
this respect.
Expression of both NaPi-IIa and NaPi-IIb was seen
in the cell membranes of cultured osteoblast-like cells
from rat and mouse. It was recently shown that both
cotransporters are also expressed in rat and mouse
odontoblasts and mouse ameloblasts [18-19]. It thus
seems that co-expression of the cotransporters is a
distinguishing feature of mineral-producing cell types,
whereas in other tissues the cotransporters are expressed
separately. NaPi-IIa has also been found in chondrocytes
and osteoclasts, however NaPi-IIb has not been studied
in these cells [20-21]. Despite the lack of one of these
cotransporters NaPi-IIa knockout mice form a fully
developed skeleton, exhibiting disturbances in bone
formation previously attributed to their hypophosphatemic
condition [20, 31]. Our finding of NaPi-IIa expression in
osteoblasts suggests that these disturbances might also
be due to a direct effect on osteoblast phosphate transport.
That the skeletal phenotype is not more severe may be
due to a compensatory role of NaPi-IIb.
Studies of Na+-Pi cotransporters expressed in
osteoblasts have thus far been limited to the ubiquitously
expressed type III cotransporters Pit-1 and Pit-2 [6-9].
However, the level of Pit-1 seems low in osteoblasts and
the transcript could not be detected by in situ hybridization
on bone [9]. In a recent paper, Zoidis and co-workers
made a comprehensive study of Na+-Pi cotransporters in
rat PyMS cells (osteoblast-like) and tissues [8]. They
detected both Pit-1 and Pit-2 in osteoblasts but did not
find expression of the type II cotransporters. The reason
for this is unclear but could be due to a phenotypic
difference betweeen PyMS and UMR-106 cells.
Previous studies of osteoblast Pi uptake have been
extensive and our data on uptake levels, and pH
dependency correlate well with earlier work with the
exception of Km values. Earlier work has often yielded
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Kmapp, Pi values around 200µM, significantly higher than
our data. However, in these studies the sodium
independent component of uptake had not been subtracted
before Km determination. Repeating our calculations with
the sodium-independent component included yielded Km
values in the low 200µM range, in good agreement with
earlier work [32-34]. Km values in this range are to be
expected for Pi uptake catalyzed by type II sodium-
phosphate cotransporters, while Km:s for type III
cotransporters are significantly lower [35]. The apparent
Km of sodium-dependent Pi uptake was unchanged
between early and late confluency for both UMR-106
and MC3T3-E1 cells. However, after showing an increase
in uptake at very acidic pH (5.6) at early confluency,
phosphate uptake in UMR-106 was altered at late
confluency, so that Pi uptake increased with rising pH
and mirrored the situation in MC3T3-E1 cells. Caverzasio
and co-workers [34] demonstrated that Pi uptake in
UMR-106 at early confluency decreased with increasing
pH, in agreement with our findings. This was taken as an
indication of type III Na+-Pi cotransporter activity in
osteoblast-like cells [29]. Not only the type III
cotransporters, however, but also NaPi-IIb show a pH
dependency where uptake decreases with increasing pH
[27], suggesting that NaPi-IIb activity is most significant
in UMR-106 at early confluency. In contrast, the activity
of NaPi-IIa, whose activity increases with rising pH,
increases with time in culture in UMR-106 cells but is
readily detectable at an early stage of growth in MC3T3-
E1 cells. Measurements of PFA inhibition of osteoblast
Pi uptake showed that the type II cotransporters were
responsible for approximately 75% of the osteoblast Pi
uptake, the remaining uninhibitable component deriving
from type III cotransporter activity that would only be
slightly inhibited (approximately 10%) (Pit-2: [13], Pit-1:
[14] and unpublished, Dr. Ian Forster, personal
communication] at the Pi and PFA concentrations used.
Western blotting of membrane proteins from these
two culture stages showed an upregulation of NaPi-IIa,
but not NaPi-IIb, one week post-confluency, mirroring
the changes seen in pH dependency of Pi uptakes. That
the phenotype of cultured osteoblast-like cells changes
with culture stage has been described previously (for a
review see ref. [36]).
Sodium-independent Pi background binding
precluded direct measurements of cellular Pi uptake in
high phosphate conditions, and to the best of our
knowledge, osteoblast phosphate uptake experiments at
elevated Pi concentrations have never been published.
We could however detect a down-regulation of NaPi-IIa
membrane protein in UMR-106, but not MC3T3-E1 cells,
after a 24 h treatment with 3mM Pi while long-term
culture in 3mM Pi medium strongly upregulated the
cotransporter in both cell lines. Expression of NaPi-IIb
was unaffected by both short and long-term treatments
with 3mM Pi in our study. This contrasted with studies
showing that in kidney and intestine, NaPi-IIa and NaPi-
IIb are down-regulated in response to elevated Pi, both
acutely and chronically, to limit phosphate influx to the
circulation and help return serum Pi to its normal
concentration [11, 17]. In hyperphosphatemia bone
formation is increased, also to remove Pi from the
circulation [37]. Upregulation of NaPi-IIa in osteoblasts,
in response to elevated concentrations of Pi would
therefore make physiological sense enabling the cells to
remove a larger amount of Pi from the circulation to
mineralizing bone. The initial down-regulation of NaPi-
IIa seen in UMR-106 cells, if not an artifact, could possibly
be a short-term response stabilizing Pi transport during
short-term fluctuations in serum Pi levels to stabilize the
rate of bone formation while the rapid response in kidney
Pi reabsorption corrects the serum Pi concentration. As
the response differed between the cell lines, definite
conclusions are hard to draw.
Pi starvation of osteoblastic cells led to a small
increase in cellular sodium-dependent phosphate uptake.
As no change in type II Na+-Pi cotransporter expression
was induced by Pi starvation, the increased uptake is most
likely due to an induction of Pit-1 that has earlier been
shown to be induced in osteoblasts by low Pi conditions
[8]. The absence of change in NaPi-IIa and NaPi-IIb
expression again suggests that the cotransporters’ role is
not in providing Pi for cellular metabolism, that would
need to be increased under Pi starvation, but in Pi
transport to forming bone, a process that would be down-
regulated as bone formation is diminished under
hypophosphatemia.
It has previously been shown that the commonly
used additions of 10mM Pi or β-glycerophosphate (from
which all phosphate is liberated within minutes after
contact with the osteoblasts), to osteoblast culture media
to promote mineralization leads to changes in osteoblast
phenotype, and to cell-independent mineralization as well
as mineral formation in fibroblast cultures [38-41]. Under
certain culture conditions elevated Pi concentrations have
also been shown to induce apoptosis in primary osteoblasts
and osteoblast-like cells [42]. No sign of Pi induced cell
death could however be detected in this study. Phosphate
is not normally considered a signalling substance but it is
now known that Pi concentration influences the expression
Osteoblast Type II Na+-Pi Cotransporters Cell Physiol Biochem 2007;19:43-56
54
osteopontin and a host of other genes in osteoblasts [43-
45]. To study physiologically relevant behaviour of
osteoblast cells it is thus necessary to keep Pi in a
physiological range. Ten mM phosphate is a
supraphysiological concentration, normal total plasma
phosphate amounting to around 1.5mM, and data in this
and previous studies suggest that a high concentration of
phosphate influences the osteoblast phenotype in a way
that might be inconsistent with normal mineralization [42-
46]. As we saw in this study, even the use of a lower
concentration of 3mM Pi to induce mineralization led to
dramatic changes in the phenotype of osteoblast cultures.
To counteract this, a concentration of 1.5mM Pi was
chosen; this both promoted mineralization in UMR-106
cultures and allowed measurements of osteoblastic Pi
uptake.
The model system of choice for studying osteoblast
mineralization is usually considered to be MC3T3-E1 cells.
However, after testing three different batches of MC3T3-
E1 cells from ATCC it was found that they did not
mineralize at Pi concentrations below 3mM, and above
that very rapidly, within 1 to 2 days, contrary to their
original characterization [47]. The above mentioned
induction of sodium-independent Pi retention was induced
in cultures already at 2mM Pi, making Pi uptake
measurements in mineralizing MC3T3-E1 cultures
impossible. Expression data for MC3T3-E1 type II Na+-
Pi cotransporters in 3mM Pi conditions have been
presented above. A possible explanation for this
observation is that ATCC propagate the cell line but do
not select it for mineralization under low Pi conditions.
The original phenotype might thus have been lost. We
therefore chose to study the development of Na+-Pi
cotransporter expression and activity in mineralizing
cultures of UMR-106 cells that formed mineral already
at 1.5mM Pi without induction of sodium-independent Pi
retention. While UMR-106 cells sometimes have been
described as forming ectopic mineral, it has ben shown
that the cell line exhibits normal osteoblastic mineralization
at Pi concentrations of 5mM or lower [48]. As described
by Bellows et. al. formation of ectopic mineral in cultures
is also greatly reduced by keeping Pi concentrations below
4mM and by allowing cultures a lag time of ECM
deposition before Pi supplementation, both conditions that
were met in the present study [38].
We have shown that, using 1.5 mM Pi
supplementation, UMR-106 cellular sodium-dependent Pi
uptake increased threefold prior to formation of mineral
in vitro; the increase in uptake starting approximately
nine days after Pi supplementation. At the same time both
NaPi-IIa and NaPi-IIb were upregulated in UMR-106
cells and upregulation correlated in magnitude with the
increased phosphate uptake. It is noteworthy that 3mM
Pi supplementation leads to a rapid increase in NaPi-IIa
expression and mineralization, while the response to
1.5mM Pi involves an upregulation of both cotransporters
and a long lag-phase prior to increased uptake and
mineralization. This suggests an ordered progression and
maturation of osteoblast cultures and extracellular matrix
prior to mineral deposition under more physiological
concentrations of Pi [38]. This closely resembles the
situation in mineralizing cultures of odontoblast-like cells
where increased sodium-dependent Pi uptake and NaPi-
IIa upregulation was seen prior to mineral formation [18].
However, NaPi-IIb was down-regulated at this stage,
pointing to differences in phosphate handling by
odontoblasts and osteoblasts. It was recently shown that
BMP-2 enhanced mineralization and Pi uptake by
MC3T3-E1 cells through an induction of Pit-1 expression
[10]. This stimulatory effect, but not basal mineralization,
was blocked by RNAi of Pit-1 showing that this
cotransporter is also of importance for osteoblast
mineralization. However the stimulation could also be
blocked by PFA at a concentration that would have no
inhibitory effect on Pit-1, suggesting that the increase in
mineralization also involved a type II cotransporter even
if this was not studied directly [10]. Our data suggests
that the type II cotransporters are responsible for most
Pi transport in mineralization, but stimulation with
osteogenic factors might lead to the requirement for a
larger contribution from the type III cotransporters.
In osteoblasts, Pi uptake has been shown to be
regulated by several calciotropic hormones, including PTH
and vitamin D, which also influence bone formation and
mineral homeostasis [32, 49, 50]. NaPi-IIa expression is
regulated in the kidney by PTH and vitamin D, and NaPi-
IIb is influenced by vitamin D in the intestine [11, 12, 24].
We consider it likely that these factors also influence
NaPi-IIa and NaPi-IIb regulation in osteoblasts which
could in part explain the factors’ control of bone formation.
After entering the osteoblast, phosphate must
subsequently be exported to the osteoid to promote
mineralization. Although the mechanism of cellular
phosphate efflux remains unknown, several different
mechanisms have been proposed ranging from diffusion
to membrane transporters [6]. In addition to these
mechanisms it is, in the case of osteoblasts, also possible
that Pi is secreted in matrix vesicles [33]. The mechanism
responsible for exporting phosphate from osteoblasts to
bone remains to be determined.
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Conclusions
We conclude that osteoblasts express two type II
Na+-Pi cotransporters, NaPi-IIa and NaPi-IIb, responsible
for the major part of osteoblast Pi uptake, in addition to
the previously detected type III cotransporters. As the
results were consistent between two different cell lines
from two different species they are likely representative
of a general osteoblastic phenotype. NaPi-IIa and NaPi-
IIb in osteoblasts are regulated by Pi concentration in a
manner consistent with the cells’ role in maintaining
phosphate homeostasis of the organism. Also, our data
suggest that an upregulation of Pi uptake and the Na+-Pi
cotransporters NaPi-IIa and NaPi-IIb is a prerequisite
for the formation of mineral by osteoblastic cells. This
strengthens the hypothesis that the flux of Pi to mineralizing
bone is largely dependent on osteoblast type II Na+-Pi
cotransporters.
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